DYN — DYNE THERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.8% (2025 Q4)
Avg. % of fund
1.43%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 835,200 +360,588 +76.0% 2.80% $16.3M $19.56
2025 Q3 ADDED 474,612 +390,182 +462.1% 1.20% $6.0M $12.65
2025 Q1 INITIATED 84,430 — — 0.28% $883K $10.46
% of Fund (quarterly)    DYN price (monthly, adj. close)

Other funds also holding DYN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 20.64% FCPM III SERVICES B.V. 14.01% Saturn V Capital Management LP 3Y 6.42% Palo Alto Investors LP 3Y 7Y 4.01% Vivo Capital, LLC 3Y 7Y 3.31% MPM BioImpact LLC 3Y 3.15% TCG Crossover Management, LLC 3Y 2.99% VR Adviser, LLC 3Y 2.1% Siren, L.L.C. 2.04% Sofinnova Investments, Inc. 3Y 7Y 1.9%
← Back to STEMPOINT CAPITAL LP Holdings